Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex
Qualigen Therapeutics, Inc. Transaction expected to significantly advance commercial readiness of NanoSynex’sinnovative diagnosticstechnology platform focused on the $30+ Billion global infectious ...